It rarely poisons you. It leaves you somewhere you cannot get out of
Warning signs
- Needing to urinate far more often than you used to — in the 2018 Global Drug Survey this was the single most reported bladder symptom among people who use ketamine, at 38 %, and it is the one that gets dismissed as nothing
- Pain in the abdomen (25 %), burning when urinating (18 %), incontinence (7 %), or blood (3 %) — the later stops on the same road
- A decreased level of consciousness — one of the common abnormal findings recorded in emergency departments, along with high blood pressure, a fast heart rate, abdominal tenderness and raised temperature
- Someone dissociated near water, cold, a height, or traffic. This is a warning sign about the place, not about the person
- Symptoms that keep coming back between sessions rather than clearing
If it goes wrong
- Move the environment before you do anything else: away from water, away from the cold, away from edges and roads. In the English death series, 16 deaths involved drowning or immersion after ketamine had caused intoxication, and impaired judgement was implicated in six falls and three road traffic accidents. The drug did not have to poison anyone for those to happen.
- Call emergency services if consciousness is decreasing, and say what else was taken — especially alcohol. Say the truth about the combination, because the combination is what the clinician is treating.
- Stay with the person. Dissociation means their own risk assessment is not available to them for a while, so it has to be yours.
- For bladder symptoms, the treatment that works is stopping. The urological literature calls cessation of ketamine use the mainstay of controlling these symptoms and of resolving the damage — and it works far better early than late.
Legal framework
| ES | Ketamine is a controlled medicine in Spain, not an uncontrolled substance and not a banned one. Order SAS/2712/2010 added it to list IV of Annex I of Royal Decree 2829/1977, which regulates psychotropic medicinal substances, applying to it the control measures and criminal penalties laid down for that list. Separately, consumption or unlawful possession of controlled substances in public places is a serious administrative offence under Organic Law 4/2015. Medical and veterinary use is lawful; non-medical supply is not. as of 2026-07-27 · Orden SAS/2712/2010, de 13 de octubre (BOE-A-2010-16025) |
|---|
This describes the law as of the date shown; it is not legal advice. The law changes and differs by country — checking yours is your responsibility.
Dangerous interactions
alcohol and other depressants life-threatening
This is where the deaths actually live. In an English series of 283 deaths in which illicitly sourced ketamine was implicated between July 1997 and January 2020, only 32 had ketamine as the sole drug implicated. Among European hospital emergency presentations involving ketamine in 2023, alcohol was noted in just over half — 55 % — of the cases where that was known. And in the EU's 2024 survey of people who use drugs, only 11 % of those who used ketamine had used it without another substance, counting tobacco and alcohol. Ketamine on its own is not what the emergency data is made of. For benzodiazepines there is a named mechanism on top of the statistics: concurrent diazepam inhibits hepatic metabolism and has been reported to prolong the plasma half-life of ketamine and its metabolites — the combination does not just add two effects, it makes one of them last longer.
European Union Drugs Agency (EUDA), European Drug Report 2025 — Other drugs; and PMC8600594
cocaine serious
In 2023 the Euro-DEN sentinel hospital emergency departments reported cocaine as the substance most often present alongside ketamine in acute toxicity presentations. In Ireland the deliberate mixing of the two has been identified at music festivals, along with ketamine-related medical incidents. This is not an accidental pairing that people stumble into; it is a common one, and it is the one that turns up at the hospital.
European Union Drugs Agency (EUDA), European Drug Report 2025 — Other drugs
a powder you did not know contained it serious
Ketamine is added to other drug mixtures, including MDMA powders, which the EU agency notes makes inadvertent consumption an issue. It is also a standard ingredient of what is sold as 'pink cocaine' or 'tucibi' — typically a mixture of ketamine, MDMA and a third substance such as cocaine, amphetamines or a new psychoactive substance. Someone can therefore take ketamine, and combine it with a stimulant, without ever deciding to do either.
European Union Drugs Agency (EUDA), European Drug Report 2025 — Other drugs
What the sources report
| insufflated | No recreational range appears in the sources this page is built from, and none is invented here. The review literature itself writes "at low doses (dosage undefined)" — when pharmacologists decline to put a number on it, a website should not. What the sources do give is the reason the same line is not the same dose twice: bioavailability differs enormously by route — intravenous 100 %, intramuscular 93 %, nasal 25–50 %, rectal 25 %, oral 17 %. Among European users surveyed, 97 % mostly snorted it, as powder or crystal. Time to effect is short, and how short depends entirely on the route: about 30 seconds intravenously, 5 to 30 minutes intranasally, 20 minutes orally. That intranasal window is the dangerous one — it is wide enough that at minute ten a person can be genuinely convinced nothing is happening. Duration of action is up to about 3 hours. The distribution half-life is roughly 24 seconds and the redistribution half-life 4 to 5 minutes, but the elimination half-life is over 2 hours: the effects fade well before the drug is gone. Recreational ketamine-related deaths notified to the National Programme on Substance Abuse Deaths, England, 1997–2019 (PMC8600594) |
|---|
The thing people check is the thing that is usually fine.
Of 704 samples handed to drug-checking services in ten EU member states, 91 % contained only the substance they were sold as, at an average purity of 86 %. By the standards of an illicit market that is remarkably honest. If your model of ketamine risk is "it might be cut with something", the data says you are worrying about the part that mostly works.
The part that does not work is everything around it.
What actually kills people
In England, 283 deaths between July 1997 and January 2020 had illicitly sourced ketamine implicated. In only 32 of them was ketamine the sole drug implicated. The recorded underlying cause was accidental poisoning in 74.6 % of cases — but reading the other cause-of-death fields tells you how people really died.
Sixteen deaths involved drowning or immersion. Impaired judgement was implicated in six falls and three road traffic accidents.
Read that again, because it is the whole point of this page. Ketamine did not have to stop anyone's breathing. It removed their ability to judge where they were, and then the water, the height and the road finished it. The published list of what dissociation exposes you to is blunt: drowning, death by hypothermia from lying outside in winter, extended exposure in water, falls from height, road traffic accidents, and becoming a crime victim.
This changes what a precaution even is. For most substances, harm reduction is about the dose. For this one it is mostly about the place and the people — no water, no cold, nothing to fall from, nobody alone. That precaution costs nothing and it is the one that maps onto how the deaths actually happened.
The other half is on a calendar, not a clock
The harm that fills clinics does not happen on the night.
Long-term users develop irritable bladder symptoms that progress to urinary frequency and urgency and eventually to a painful ulcerated bladder. Continue and it reaches the kidneys: hydronephrosis, ureteral stricture, and chronic renal insufficiency. In severe cases the urological literature is plain about what is left — only augmentation enterocystoplasty, a bladder rebuilt using bowel, can relieve the pain and restore function.
Two numbers matter here. The incidence of lower urinary tract symptoms among heavy ketamine users has been put at around 30 % in a Hong Kong study. And the interval from starting to the first symptoms varies from a few weeks to years — so "I have only been doing this a little while" is not the protection it sounds like.
The Netherlands has had to establish clinics specialising in urological problems caused by chronic intensive ketamine use. That is what the scale of this looks like from the health-system side.
Why the first symptom gets ignored
In the 2018 Global Drug Survey, the most reported bladder symptom was urinary frequency, at 38 %. Then abdominal pain at 25 %, burning when urinating at 18 %, incontinence at 7 %, blood at 3 %.
The first one does not feel like a medical event. It feels like drinking too much, or a small bladder, or nothing. It is the only symptom on that list that arrives while the damage is still reversible, and it is the one designed to be dismissed.
The treatment is not a drug. Cessation is the mainstay of controlling these symptoms and resolving the damage — and the earlier it happens, the more of the bladder there is left to save.
A legal status that is genuinely different
Unlike the other substances documented on this site, ketamine is not under international control. The EU agency describes it as an essential medicine not subject to international control, and names exactly that as the reason monitoring it is difficult. In 2006 the UN Commission on Narcotic Drugs urged member states to consider controlling it under their own national legislation rather than scheduling it internationally.
So the answer to "is it legal" is genuinely different in different countries, more so than for almost anything else described here. Spain answered in 2010 by putting it in list IV. Yours may have answered differently, and only its current text tells you.
The honest summary
The bag is usually what it says it is. The risk is in the combination, in the place, and in the calendar — and only one of those three is visible on the night.
Sources
- Recreational ketamine-related deaths notified to the National Programme on Substance Abuse Deaths, England, 1997–2019 (PMC8600594) (retrieved 2026-07-27)
- Pathophysiology, clinical presentation, and management of ketamine-induced cystitis (PMC10399845) (retrieved 2026-07-27)
- European Union Drugs Agency (EUDA), European Drug Report 2025 — Other drugs: the current situation in Europe (retrieved 2026-07-27)
- European Union Drugs Agency (EUDA), Ketamine in Europe: EMPACT situation report (retrieved 2026-07-27)
- Orden SAS/2712/2010, de 13 de octubre (BOE-A-2010-16025) (retrieved 2026-07-27)